17.3 Data Correction and Audit Trails
Key Takeaways
- Audit trails provide a computer-generated, time-stamped history of every change made in an EDC system
- Data correction must always adhere to ALCOA-C principles
- 21 CFR Part 11 sets the standards for electronic records and audit trail compliance in clinical trials
In clinical research, the ability to trace the history of data from its initial creation to its final archival is paramount. Data correction is a routine part of trial management, but it must be conducted transparently and strictly adhere to regulatory guidelines. Central to this transparency is the concept of the audit trail.
The Importance of Audit Trails
An audit trail is a secure, computer-generated, time-stamped electronic record that allows for the reconstruction of the course of events relating to the creation, modification, or deletion of an electronic record.
In simple terms, it is the "history log" of a data point. If a value in the Electronic Data Capture (EDC) system is changed, the audit trail records:
- Who made the change (identified by their unique user ID).
- When the change was made (date and exact time).
- What the original value was and what the new value is.
- Why the change was made (the reason for the modification).
Regulatory Foundations: 21 CFR Part 11
In the United States, the Food and Drug Administration (FDA) regulates electronic records and electronic signatures under Title 21 of the Code of Federal Regulations, Part 11 (commonly referred to as 21 CFR Part 11).
For an EDC system to be compliant with Part 11, it must possess an automated, secure audit trail that cannot be altered or deleted by any user, including system administrators. The audit trail must begin the moment a record is first saved and capture every subsequent modification. During regulatory inspections, FDA auditors frequently review audit trails to look for suspicious patterns, such as data being manipulated to fit study endpoints.
ALCOA-C Principles and Data Correction
When correcting data, whether on paper or electronically, the principles of ALCOA-C must be maintained to ensure data integrity.
| Principle | Meaning in the Context of Data Correction |
|---|---|
| Attributable | It must be clear who made the correction. In EDC, this is handled by unique user logins. On paper, it requires initials and signatures. |
| Legible | The original entry must remain visible. Corrections should never obscure the initial data (no white-out or scribbling over). |
| Contemporaneous | The correction should be recorded at the time it is made, and the time/date must be accurate. |
| Original | The earliest record of the data is the source. The EDC must reflect the original source document. |
| Accurate | The corrected data must reflect the truth of what occurred or what was observed. |
| Complete | No data should be omitted to hide errors; all relevant context must be provided. |
Correcting Data in Electronic Systems (EDC)
Correcting data in modern EDC systems is highly structured. When a Clinical Research Coordinator (CRC) needs to change a previously saved data point (often in response to a query), the system will prompt them for a reason for the change.
Acceptable Reasons for Change
EDC systems typically provide a drop-down menu of standard reasons for changing data, such as:
- Typographical error
- Incorrect date format
- New information available
- Transcription error from source
If a drop-down option does not accurately describe the reason, the CRC must type a clear, concise explanation. Vague reasons like "fixing mistake" or "updating" are generally frowned upon during audits; specific reasons like "Transposed systolic and diastolic values" are preferred.
What NOT to Do in EDC
- Never share login credentials. Because the audit trail tracks changes by user ID, sharing a password means you are legally signing off on someone else's work.
- Never alter data to clear a query without checking the source. If the EDC requires a change, the source document must support that change.
Correcting Data on Paper (Paper CRFs and Source Documents)
While EDC is the standard, paper records (such as source document worksheets, patient diaries, and occasionally paper CRFs) are still prevalent. Correcting errors on paper requires strict adherence to Good Clinical Practice (GCP).
The GCP Correction Method
When an error is made on a paper record, the CRC must:
- Draw a single horizontal line through the incorrect entry. The original entry must remain readable.
- Write the correct information adjacent to the error.
- Write their initials and the current date next to the correction.
- If the reason for the correction is not obvious, provide a brief explanation (e.g., "wrong date," "transcription error").
Prohibited Practices on Paper:
- Never use correction fluid (White-Out).
- Never use pencils (all entries must be in permanent ink).
- Never scribble or heavily cross out an entry so it cannot be read.
- Never backdate a correction (always use the date the correction is actually being made).
Data Clarification Forms (DCFs)
In trials that still use paper Case Report Forms, queries are often managed using a Data Clarification Form (DCF).
- The data management team identifies a discrepancy on the submitted paper CRF.
- A DCF is generated and sent to the site.
- The CRC reviews the DCF, writes the correct information directly on the form, signs and dates it, and returns it to data management.
- The DCF serves as the audit trail for the paper correction, linking the original CRF entry to the updated database value.
Consequences of Inadequate Audit Trails
The integrity of the audit trail is a primary focus during FDA site inspections. If an auditor discovers that data was changed without proper documentation, or if the audit trail reveals suspicious activity (e.g., multiple critical efficacy endpoints changed by the Principal Investigator just before database lock without source justification), the consequences can be severe.
Outcomes of audit trail violations include:
- Rejection of the clinical trial data by regulatory agencies.
- Issuance of an FDA Form 483 (Notice of Inspectional Observations) or a Warning Letter.
- In extreme cases involving fraud, criminal prosecution and debarment from participating in future clinical research.
Maintaining accurate, transparent corrections and respecting the audit trail is not merely administrative overhead; it is the bedrock of ethical and scientifically valid clinical research.
Which FDA regulation specifically governs electronic records and requires secure, computer-generated audit trails?
According to GCP guidelines, how should a correction be made on a paper source document?
Why is sharing EDC login credentials strictly prohibited in clinical research?